Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 554261 - 554280 out of 556105 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01FD01) trastuzumab (adm: P) | HERZUMA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab (adm: P) | HERZUMA 420MG/VIAL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | TevaPharmaceuticalsUSA,Inc. |
| USA | (L01FD01) trastuzumab (adm: P) | KANJINTI 420MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FD01) trastuzumab (adm: P) | KANJINTI 420MG/VIAL INJ | 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 100MG/5ML INJ,SOLN SDV | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 100MG/5ML INJ,SOLN SDV | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 400G/20ML INJ,SOLN SDV | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FE02) panitumumab | VECTIBIX 400G/20ML INJ,SOLN SDV | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenUSA,Inc. |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 120MG INJ | 120MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF03) durvalumab (adm: P) | IMFINZI 500MG INJ | 500MG | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FF06) cemiplimab (adm: P) | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF06) cemiplimab (adm: P) | LIBTAYO 50MG/ML INJ,VIL,7ML | 1X7ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | RegeneronPharmaceuticals,Inc. |
| USA | (L01FF13) toripalimab | LOQTORZI 40MG/ML INJ,SOLN | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Nasopharyngeal Carcinoma;Esophageal Squamous Cell Carcinoma | CoherusBioSciences,Inc. |
| USA | (L01FF13) toripalimab | LOQTORZI 40MG/ML INJ,SOLN | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Nasopharyngeal Carcinoma;Esophageal Squamous Cell Carcinoma | CoherusBioSciences,Inc. |
| USA | (L01FG01) bevacizumab | ZIRABEV 100MG | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FG01) bevacizumab | ZIRABEV 400MG | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PfizerInc. |
| USA | (L01FG01) bevacizumab | JOBEVNE 25MG/ML INJ,SOLN,16ML | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BioconBiologics,Inc. |
| USA | (L01FG01) bevacizumab | JOBEVNE 25MG/ML INJ,SOLN,16ML | 16ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BioconBiologics,Inc. |
Pages
